On Invalid Date, First Wave Biopharma (NASDAQ: FWBI) reported Q3 2023 earnings per share (EPS) of -$9.20, up 102.49% year over year. Total First Wave Biopharma earnings for the quarter were -$3.48 million. In the same quarter last year, First Wave Biopharma's earnings per share (EPS) was $370.20.
As of Q1 2024, First Wave Biopharma's earnings has grown year over year. First Wave Biopharma's earnings in the past year totalled -$15.91 million.
What is FWBI's earnings date?
First Wave Biopharma's earnings date is Invalid Date. Add FWBI to your watchlist to be reminded of FWBI's next earnings announcement.
What was FWBI's revenue last quarter?
On Invalid Date, First Wave Biopharma (NASDAQ: FWBI) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, First Wave Biopharma's revenue was $0.00.
What was FWBI's revenue growth in the past year?
As of Q1 2024, First Wave Biopharma's revenue has grown null year over year. First Wave Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.